Log in
Enquire now
‌

US Patent 10881657 Bupropion as a modulator of drug activity

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10881657
Date of Patent
January 5, 2021
Patent Application Number
16359958
Date Filed
March 20, 2019
Patent Citations
‌
US Patent 10548857 Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects
‌
US Patent 10596167 Compositions and methods comprising bupropion or related compounds for sustained delivery of dextromethorphan
‌
US Patent 10688066 Bupropion and dextromethorphan for treating nicotine addiction
‌
US Patent 10772850 Bupropion as a modulator of drug activity
‌
US Patent 10780064 Bupropion as a modulator of drug activity
‌
US Patent 10780066 Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects
‌
US Patent 10786469 Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects
‌
US Patent 10786496 Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects
...
Patent Citations Received
‌
US Patent 12109178 Bupropion as a modulator of drug activity
0
‌
US Patent 11497721 Bupropion as a modulator of drug activity
‌
US Patent 11510918 Bupropion as a modulator of drug activity
‌
US Patent 11517542 Bupropion as a modulator of drug activity
‌
US Patent 11517544 Bupropion as a modulator of drug activity
‌
US Patent 11517543 Bupropion as a modulator of drug activity
‌
US Patent 11524007 Bupropion as a modulator of drug activity
‌
US Patent 11524008 Bupropion as a modulator of drug activity
...
Patent Primary Examiner
‌
Bong-Sook Baek
Patent abstract

Dosage forms, drug delivery systems, and methods related to sustained release of dextromethorphan or improved therapeutic effects are disclosed. Typically, bupropion or a related compound is orally administered to a human being to be treated with, or being treated with, dextromethorphan.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10881657 Bupropion as a modulator of drug activity

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.